Results 121 to 130 of about 235,874 (246)

Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study

Scientific Reports
Although allogeneic hematopoietic cell transplantation (HCT) is an alternative treatment for relapsed or refractory (R/R) acute promyelocytic leukemia (APL), little is known regarding the utility of allogeneic HCT for R/R therapy-related APL (t-APL).
Satoshi Yamasaki, Masamitsu Yanada, Hiroaki Araie, Takahiro Fukuda, Yoshinobu Kanda, Haruko Tashiro, Naoyuki Uchida, Kazutaka Ozeki, Shuichi Ota, Yasushi Onishi, Noriko Doki, Tatsuo Oyake, Satoru Takada, Masatoshi Sakurai, Yukio Kondo, Hirohisa Nakamae, Toshiro Kawakita, Makoto Onizuka, Yoshiko Atsuta, Takaaki Konuma   +19 more
doaj   +1 more source

Erratum to “Development and Validation of a LC/MS/MS Method for the Determination of Duloxetine in Human Plasma and Its Application to Pharmacokinetic Study”

Journal of Chemistry, 2013
D. Chandrapal Reddy, A. T. Bapuji, V. Suryanarayana Rao, V. Himabindu, D. Rama Raju, Syed Syedba, H. L. V. Ravikiran   +6 more
doaj   +1 more source

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French‐Belgian‐Swiss APL group

Cancer, 2015
T. Braun, S. Cereja, S. Chevret, E. Raffoux, M. Beaumont, L. Detourmignies, A. Pigneux, X. Thomas, D. Bordessoule, A. Guerci, T. Lamy, C. Récher, X. Poiré, O. Tournilhac, O. Spertini, C. Chomienne, L. Degos, H. Dombret, L. Adès, P. Fenaux   +19 more
semanticscholar   +1 more source

Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients

Leukemia, 2014
Ramy Rahmé, X. Thomas, C. Récher, N. Vey, J. Delaunay, E. Deconinck, P. Hirsch, D. Bordessoule, J. Micol, A. Stamatoullas, C. Mariette, C. Pautas, P. Bories, J. Marolleau, M. Hunault-Berger, N. Fegueux, E. Raffoux, H. Dombret, L. Degos, P. Fenaux, L. Adès   +20 more
semanticscholar   +1 more source

Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome. [PDF]

Rheumatology (Oxford)
Gaspar P, Cruz-Machado AR, Abrantes AM, Costa F, Parreira I, Lopes AR, Costa-Silva R, Chícharo AT, Martins JR, Marques JP, Santos D, Romão VC, Graca L, Fonseca JE.   +13 more
europepmc   +1 more source

Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.

Blood, 2014
Adeline Vitaliano-Prunier, Juliane Halftermeyer, Julien Ablain, A. de Reyniès, L. Pérès, M. Le Bras, D. Metzger, H. de Thé   +7 more
semanticscholar   +1 more source

Association between leukemic immunophenotype and overall survival in patients with acute promyelocytic leukemia: a retrospective cohort study. [PDF]

Front Cell Dev Biol
Zha X, Ma L, Yue Y, Wei X, Sun B, Wang W.   +5 more
europepmc   +1 more source

Contemporary Treatment of APL

Current Hematologic Malignancy Reports, 2014
E. Cull, J. Altman
semanticscholar   +1 more source

AML With Myelodysplasia Related Changes With APL-Like Morphology. [PDF]

Clin Case Rep
Roldán Galiacho V, Plazaola Matilla I, Dávila de Las Fuentes B, García Naveda L, Ancín Arteaga I.   +4 more
europepmc   +1 more source

Compiling a Subset of APL Into a Typed Intermediate Language

ARRAY@PLDI, 2014
M. Elsman, M. Dybdal
semanticscholar   +1 more source